Lawsuit against drug price cut getting fierce

A legal suit, ignited by Korean pharmaceutical firms, is getting fiercer as GUJU pharm and YOUNG POONG pharm unveiled their plans to defend their drug prices, which were reduced by the government’ anti-rebate rule, in the Seoul Administration Court on April 4.

In August 200, the Ministry of Health and Welfare launched a crackdown on unlawful drug marketing activities. It introduced a rule wh...